Royal Bank of Canada’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$220M Sell
391,704
-6,619
-2% -$4.24M 0.04% 381
2025
Q4
$269M Buy
398,323
+60,573
+18% +$41.3M 0.04% 342
2025
Q3
$216M Sell
337,750
-70,502
-17% -$42.8M 0.04% 411
2025
Q2
$219M Buy
408,252
+68,564
+20% +$32.8M 0.04% 373
2025
Q1
$143M Sell
339,688
-141,452
-29% -$61.4M 0.03% 434
2024
Q4
$199M Buy
481,140
+42,364
+10% +$18.6M 0.04% 362
2024
Q3
$222M Sell
438,776
-33,112
-7% -$16.1M 0.05% 336
2024
Q2
$230M Buy
471,888
+185,778
+65% +$93.3M 0.05% 300
2024
Q1
$154M Buy
286,110
+27,456
+11% +$15M 0.04% 377
2023
Q4
$144M Buy
258,654
+40,427
+19% +$19M 0.03% 407
2023
Q3
$95.4M Sell
218,227
-857
-0.4% -$427K 0.03% 479
2023
Q2
$110M Buy
219,084
+36,611
+20% +$17.5M 0.03% 454
2023
Q1
$91.3M Sell
182,473
-3,736
-2% -$1.79M 0.03% 484
2022
Q4
$76M Buy
186,209
+1,129
+0.6% +$438K 0.02% 548
2022
Q3
$60.3M Sell
185,080
-1,033
-0.6% -$379K 0.02% 586
2022
Q2
$65.3M Sell
186,113
-43,526
-19% -$17.7M 0.02% 565
2022
Q1
$126M Sell
229,639
-36,055
-14% -$19M 0.03% 430
2021
Q4
$175M Sell
265,694
-18,862
-7% -$11.8M 0.04% 361
2021
Q3
$177M Sell
284,556
-43,569
-13% -$29.3M 0.05% 329
2021
Q2
$207M Sell
328,125
-40,620
-11% -$22.4M 0.06% 290
2021
Q1
$180M Sell
368,745
-61,567
-14% -$30.8M 0.05% 308
2020
Q4
$215M Buy
430,312
+82,015
+24% +$36.7M 0.06% 264
2020
Q3
$137M Buy
348,297
+21,514
+7% +$7.95M 0.05% 313
2020
Q2
$108M Sell
326,783
-21,543
-6% -$6.24M 0.04% 342
2020
Q1
$84.4M Sell
348,326
-37,104
-10% -$9.68M 0.04% 337
2019
Q4
$101M Buy
385,430
+80,351
+26% +$21.2M 0.04% 394
2019
Q3
$83M Buy
305,079
+5,031
+2% +$1.4M 0.03% 414
2019
Q2
$82.6M Sell
300,048
-31,066
-9% -$7.65M 0.03% 407
2019
Q1
$74M Buy
331,114
+66,339
+25% +$13.7M 0.03% 429
2018
Q4
$49.3M Buy
264,775
+55,353
+26% +$11.3M 0.02% 521
2018
Q3
$52.2M Buy
209,422
+38,321
+22% +$9.3M 0.02% 568
2018
Q2
$37.3M Sell
171,101
-626
-0.4% -$129K 0.02% 708
2018
Q1
$32.9M Sell
171,727
-30,833
-15% -$5.69M 0.01% 771
2017
Q4
$31.7M Sell
202,560
-58,215
-22% -$9.16M 0.01% 850
2017
Q3
$40.5M Buy
260,775
+17,837
+7% +$2.82M 0.02% 668
2017
Q2
$39.2M Buy
242,938
+57,594
+31% +$9.35M 0.02% 653
2017
Q1
$28.7M Sell
185,344
-12,035
-6% -$1.66M 0.02% 798
2016
Q4
$23.1M Sell
197,379
-3,039
-2% -$347K 0.01% 963
2016
Q3
$22.6M Sell
200,418
-7,260
-3% -$765K 0.01% 932
2016
Q2
$19.3M Buy
207,678
+14,458
+7% +$1.24M 0.01% 990
2016
Q1
$15.1M Sell
193,220
-4,124
-2% -$297K 0.01% 1115
2015
Q4
$14.4M Sell
197,344
-19,175
-9% -$1.37M 0.01% 1185
2015
Q3
$16.1M Sell
216,519
-113,584
-34% -$8.14M 0.01% 884
2015
Q2
$21.2M Buy
330,103
+19,127
+6% +$1.32M 0.01% 789
2015
Q1
$24M Buy
310,976
+1,604
+0.5% +$125K 0.02% 721
2014
Q4
$22.9M Sell
309,372
-15,976
-5% -$1.12M 0.01% 772
2014
Q3
$19.2M Buy
325,348
+874
+0.3% +$55.3K 0.01% 827
2014
Q2
$21.7M Buy
324,474
+436
+0.1% +$27.7K 0.01% 766
2014
Q1
$19.7M Buy
324,038
+532
+0.2% +$31.7K 0.01% 767
2013
Q4
$17.2M Sell
323,506
-96,306
-23% -$5.07M 0.01% 877
2013
Q3
$20.9M Buy
419,812
+35,360
+9% +$1.7M 0.02% 713
2013
Q2
$17.3M Buy
+384,452
New +$16.8M 0.01% 743

Other funds holding IDXX

Royal Bank of Canada's IDXX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Idexx Laboratories (IDXX) stake by 1.7% in Q1 2026, selling an estimated $4.24M and leaving 391,704 shares worth $220M. The position accounts for 0.04% of the portfolio, ranked #381.

Royal Bank of Canada first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $269M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Royal Bank of Canada held 391,704 shares of Idexx Laboratories worth $220M as of Q1 2026.
  • Royal Bank of Canada sold 6,619 Idexx Laboratories shares in Q1 2026, an estimated $4.24M.
  • Idexx Laboratories made up 0.04% of Royal Bank of Canada's portfolio in Q1 2026, its #381 holding.
  • Royal Bank of Canada first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Idexx Laboratories position peaked at $269M in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.